ATLANTA--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the introduction of three new bio-imaging products to strengthen its commitment to enabling earlier detection of disease indicators and faster discovery of effective new drugs. The new tools, announced at the Neuroscience 2006 show in Atlanta, Georgia, fortify PerkinElmer’s increased focus on bio-imaging by offering high-performance, research-grade systems and powerful software, providing scientists with greater insights into their research.
